Investor Presentaiton
о
For personal use only
FY20 Business update
FY20 Revenue mix
Two operating segments
Software
47.5
35.0
15.3
26.8
19.7
20.7
$47.5m
37.3% of Total Revenue
35.7% growth
■ Enterprise
■ Health
FY19
FY20
Bo
Services
80.1
63.2
49.1
28.2
Citadel Group | Investor Presentation | 7
$80.1m
62.7% of Total Revenue
26.7% growth
35.0
31.0
Professional
■Technology
FY19
FY20
Health Software
> 10 year contract extension of the Queensland Health contract until 2029
to continue to provide Auslab™ and the upgrade to Auslab Evolution™
> Wellbeing awarded NIMIS contract in Ireland (7 years, £3.6m TCV)
Revenue to commence in FY21
Professional Services
> Early extension of Defence contract out to July 2021
> Revenue from Noventus $21.5m, ahead of expectations with no material impact
from COVID-19
> Entered into strategic partnership with LeanIX - enterprise architecture software
Enterprise Software
> Revenue growth in Citadel Information Exchange (Citadel-IX™M) of 66.5%
> Launch of goTRIM Pro™, an advanced mobile Content Manager
interface
> Extending current partnership with Micro Focus, developing a significant
global Big Pharma client pipeline
Technology
> 3 year managed services contract for AV/VC support with
University of Melbourne - engaged by three of the Group of Eight (G8) universities
> $9.7m+ building works contract won in May 2020, with $2.5m recognised in FY20
and remainder to be delivered in FY21View entire presentation